Methods and compositions for RNA interference
View Patent ↗The invention provides methods and compositions for gene silencing by RNA interference. In particular, the invention provides methods for gene silencing or RNA knockdown using small interfering RNAs (siRNAs) having partial sequence homology to its target gene. The invention also provides methods for identifying common and/or differential responses to a plurality of different siRNAs targeting a gene. The invention also provides methods for evaluating the relative activity of the two strands of an siRNA. The invention further provides methods of designing siRNAs for gene silencing. The invention further provides methods of using siRNAs as therapeutics for treatment of diseases.
1. A method of designing a small interfering RNA (“siRNA”) for silencing a first gene but not a second gene in a eukaryotic cell by RNA interference, comprising selecting an siRNA sequence that is characterized as:
(a) comprising a central contiguous nucleotide sequence of at least 11 nucleotides that is (i) identical to a sequence of a transcript of said first gene or (ii) identical to the reverse complement of a sequence of a transcript of said first gene;
(b) lacking any central contiguous nucleotide sequence of more than 10 nucleotides that is identical to a sequence of a transcript of said second gene and lacking any central contiguous nucleotide sequence of more than 10 nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene; and
(c) lacking any 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is identical to a sequence of said transcript of said second gene and lacking any 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene;
said central contiguous nucleotide sequence being in the central region of said siRNA; said 3′ end contiguous nucleotide sequence terminating within 3 nucleotides of the 3′ end of said siRNA; wherein said selecting step is performed by a suitably programmed computer.
2. The method of claim 1 , wherein said selecting is for an siRNA that is characterized as lacking any central contiguous nucleotide sequence of greater than 8 nucleotides in length that is identical to a sequence of said transcript of said second gene and lacking any central contiguous nucleotide sequence of greater than 8 nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene.
3. A method of designing a siRNA for silencing a first gene but not a second gene in a eukaryotic cell by RNA interference, comprising selecting an siRNA that is characterized as:
(a) comprising a 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is (i) identical to a sequence of a transcript of said first gene or (ii) identical to the reverse complement of a sequence of a transcript of said first gene;
(b) lacking any central contiguous nucleotide sequence of more than 10 nucleotides that is identical to a sequence of a transcript of said second gene and lacking any central contiguous nucleotide sequence of more than 10 nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene; and
(c) lacking any 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is identical to a sequence of said transcript of said second gene and lacking any 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene;
said central contiguous nucleotide sequence being in the central region of said siRNA; said 3′ end contiguous nucleotide sequence terminating within 3 nucleotides of the 3′ end of said siRNA; wherein said selecting step is performed by a suitably programmed computer.
4. The method of claim 3 , wherein said selecting is for an siRNA that is characterized as lacking any central contiguous nucleotide sequence of greater than 8 nucleotides in length that is identical to a sequence of said transcript of said second gene and lacking any central contiguous nucleotide sequence of greater than 8 nucleotides that is identical to the reverse complement of a sequence of a transcript of the second gene.
5. The method of claim 1 wherein said central contiguous nucleotide sequence in (a) is 11-15 nucleotides in length.
6. The method of claim 5 , wherein said central contiguous nucleotide sequence in (a) is 14-15 nucleotides in length.
7. The method of claim 5 , wherein said central contiguous nucleotide sequence in (a) is 13 nucleotides in length.
8. The method of claim 5 , wherein said central contiguous nucleotide sequence in (a) is 12 nucleotides in length.
9. The method of claim 5 , wherein said central contiguous nucleotide sequence in (a) is 11 nucleotides in length.
10. The method of claim 3 , wherein said 3′ end contiguous nucleotide sequence in (a) is 9-15 nucleotides in length.
11. The method of claim 10 , wherein said 3′ end contiguous nucleotide sequence in (a) is 9-12 nucleotides in length.
12. The method of claim 11 , wherein said 3′ end contiguous nucleotide sequence in (a) is 10 nucleotides in length.
13. The method of claim 11 , wherein said 3′ end contiguous nucleotide sequence in (a) is 9 nucleotides in length.
14. A computer program product for use in conjunction with a computer system, the computer program product comprising a computer readable storage medium and a computer program mechanism embedded therein, the computer program mechanism being for designing an siRNA for silencing a first gene but not a second gene in a eukaryotic cell by RNA interference, the computer program mechanism comprising executable instructions for performing a method comprising selecting an siRNA sequence that is characterized as:
(a) comprising a central contiguous nucleotide sequence of at least 11 nucleotides that is (i) identical to a sequence of a transcript of said first gene or (ii) identical to the reverse complement of a sequence of a transcript of said first gene;
(b) lacking any central contiguous nucleotide sequence of more than 10 nucleotides that is identical to a sequence of a transcript of said second gene and lacking any central contiguous nucleotide sequence of more than 10 nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene; and
(c) lacking any 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is identical to a sequence of said transcript of said second gene and lacking any 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene;
said central contiguous nucleotide sequence being in the central region of said siRNA; said 3′ end contiguous nucleotide sequence terminating within 3 nucleotides of the 3′ end of said siRNA.
15. The computer program product of claim 14 , wherein said selecting is for an siRNA that is characterized as lacking a any central contiguous nucleotide sequence of greater than 8 nucleotides in length that is identical to a sequence of said transcript of said second gene and lacking any central contiguous nucleotide sequence of greater than 8 nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene.
16. The computer program product of claim 14 wherein said central contiguous nucleotide sequence in (a) is 11-15 nucleotides in length.
17. The computer program product of claim 16 , wherein said central contiguous nucleotide sequence in (a) is 14-15 nucleotides in length.
18. The computer program product of claim 16 , wherein said central contiguous nucleotide sequence in (a) is 13 nucleotides in length.
19. The computer program product of claim 16 , wherein said central contiguous nucleotide sequence in (a) is 12 nucleotides in length.
20. The computer program product of claim 16 , wherein said central contiguous nucleotide sequence in (a) is 11 nucleotides in length.
21. A computer program product for use in conjunction with a computer system, the computer program product comprising a computer readable storage medium and a computer program mechanism embedded therein, the computer program mechanism being for designing an siRNA for silencing a first gene but not a second gene in a eukaryotic cell by RNA interference, the computer program mechanism comprising executable instructions for performing a method comprising selecting an siRNA sequence that is characterized as:
(a) comprising a 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is (i) identical to a sequence of said transcript of said first gene or (ii) identical to the reverse complement of a sequence of a transcript of said first gene;
(b) lacking any central contiguous nucleotide sequence of more than 10 nucleotides that is identical to a sequence of a transcript of said second gene and lacking any central contiguous nucleotide sequence of more than 10 nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene; and
(c) lacking any 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is identical to a sequence of said transcript of said second gene and lacking any 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene;
said central contiguous nucleotide sequence being in the central region of said siRNA; said 3′ end contiguous nucleotide sequence terminating within 3 nucleotides of the 3′ end of said siRNA.
22. The computer program product of claim 21 , wherein said selecting is of an siRNA that is characterized as lacking any central contiguous nucleotide sequence of greater than 8 nucleotides in length that is identical to a sequence of said transcript of said second gene and lacking any central contiguous nucleotide sequence of greater than 8 nucleotides that is identical to the reverse complement of a sequence of a transcript of the second gene.
23. The computer program product of claim 21 , wherein said 3′ end contiguous nucleotide sequence in (a) is 9-15 nucleotides in length.
24. The computer program product of claim 23 , wherein said 3′ end contiguous nucleotide sequence in (a) is 9-12 nucleotides in length.
25. The computer program product of claim 24 , wherein said 3′ end contiguous nucleotide sequence in (a) is 10 nucleotides in length.
26. The computer program product of claim 24 , wherein said 3′ end contiguous nucleotide sequence in (a) is 9 nucleotides in length.
27. A computer system for designing an siRNA for silencing a first gene but not a second gene in a eukaryotic cell by RNA interference, the computer system comprising:
a central processing unit;
a memory, coupled to the central processing unit, the memory storing one or more programs that cause the central processing unit to perform a method comprising selecting an siRNA sequence that is characterized as:
(a) comprising a central contiguous nucleotide sequence of at least 11 nucleotides that is (i) identical to a sequence of a transcript of said first gene or (ii) identical to the reverse complement of a sequence of a transcript of said first gene;
(b) lacking any central contiguous nucleotide sequence of more than 10 nucleotides that is identical to a sequence of a transcript of said second gene and lacking any central contiguous nucleotide sequence of more than 10 nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene; and
(c) lacking any 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is identical to a sequence of said transcript of said second gene and lacking any 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene;
said central contiguous nucleotide sequence being in the central region of said siRNA; said 3′ end contiguous nucleotide sequence terminating within 3 nucleotides of the 3′ end of said siRNA.
28. The computer system of claim 27 , wherein said selecting is for an siRNA that is characterized as lacking any central contiguous nucleotide sequence of greater than 8 nucleotides in length that is identical to a sequence of said transcript of said second gene and lacking any central contiguous nucleotide sequence of greater than 8 nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene.
29. The computer system of claim 27 wherein said central contiguous nucleotide sequence in (a) is 11-15 nucleotides in length.
30. The computer system of claim 29 , wherein said central contiguous nucleotide sequence in (a) is 14-15 nucleotides in length.
31. The computer system of claim 29 , wherein said central contiguous nucleotide sequence in (a) is 13 nucleotides in length.
32. The computer system of claim 29 , wherein said central contiguous nucleotide sequence in (a) is 12 nucleotides in length.
33. The computer system of claim 29 , wherein said central contiguous nucleotide sequence in (a) is 11 nucleotides in length.
34. A computer system for designing an siRNA for silencing a first gene but not a second gene in a eukaryotic cell by RNA interference, the computer system comprising:
a central processing unit;
a memory, coupled to the central processing unit, the memory storing one or more programs that cause the central processing unit to perform a method comprising selecting an siRNA sequence that is characterized as:
(a) comprising a 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is (i) identical to a sequence of said transcript of said first gene or (ii) identical to the reverse complement of a sequence of a transcript of said first gene;
(b) lacking any central contiguous nucleotide sequence of more than 10 nucleotides that is identical to a sequence of a transcript of said second gene and lacking any central contiguous nucleotide sequence of more than 10 nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene; and
(c) lacking any 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is identical to a sequence of said transcript of said second gene and lacking any 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene;
said central contiguous nucleotide sequence being in the central region of said siRNA; said 3′ end contiguous nucleotide sequence terminating within 3 nucleotides of the 3′ end of said siRNA.
35. The computer system of claim 34 , wherein said selecting is of an siRNA that is characterized as lacking any central contiguous nucleotide sequence of greater than 8 nucleotides in length that is identical to a sequence of said transcript of said second gene and lacking any central contiguous nucleotide sequence of greater than 8 nucleotides in length that is identical to the reverse complement of a sequence of a transcript of said second gene.
36. The computer system of claim 34 , wherein said 3′ end contiguous nucleotide sequence in (a) is 9-15 nucleotides in length.
37. The computer system of claim 36 , wherein said 3′ end contiguous nucleotide sequence in (a) is 9-12 nucleotides in length.
38. The computer system of claim 37 , wherein said 3′ end contiguous nucleotide sequence in (a) is 10 nucleotides in length.
39. The computer system of claim 37 , wherein said 3′ end contiguous nucleotide sequence in (a) is 9 nucleotides in length.
40. A method of designing a small interfering RNA (“siRNA”) for silencing a first gene but not a second gene in a eukaryotic cell by RNA interference, comprising:
(a) selecting an siRNA sequence that is characterized as (i) comprising a central contiguous nucleotide sequence of at least 11 nucleotides that is (1) identical to a sequence of a transcript of said first gene or (2) identical to the reverse complement of a sequence of a transcript of said first gene; (ii) lacking any central contiguous nucleotide sequence of more than 10 nucleotides that is identical to a sequence of a transcript of said second gene and lacking any central contiguous nucleotide sequence of more than 10 nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene; and (iii) lacking any 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is identical to a sequence of said transcript of said second gene and lacking any 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene; said central contiguous nucleotide sequence being in the central region of said siRNA; said 3′ end contiguous nucleotide sequence terminating within 3 nucleotides of the 3′ end of said siRNA; and
(b) performing an assay to evaluate the siRNA sequence selected according to (a) for efficacy in silencing the target gene.
41. A method of designing a siRNA for silencing a first gene but not a second gene in a eukaryotic cell by RNA interference, comprising:
(a) selecting an siRNA that is characterized as (i) comprising a 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is (1) identical to a sequence of a transcript of said first gene or (2) identical to the reverse complement of a sequence of a transcript of said first gene; (ii) lacking any central contiguous nucleotide sequence of more than 10 nucleotides that is identical to a sequence of a transcript of said second gene and lacking any central contiguous nucleotide sequence of more than 10 nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene; and (iii) lacking any 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is identical to a sequence of said transcript of said second gene and lacking any 3′ end contiguous nucleotide sequence of 8 or more nucleotides that is identical to the reverse complement of a sequence of a transcript of said second gene; said central contiguous nucleotide sequence being in the central region of said siRNA; said 3′ end contiguous nucleotide sequence terminating within 3 nucleotides of the 3′ end of said siRNA; and
(b) performing an assay to evaluate the siRNA sequence selected according to (a) for efficacy in silencing the target gene.